Status:
COMPLETED
The Effect of Volitional Pursed-lips Breathing
Lead Sponsor:
Karl Josef Franke, PD DR med
Conditions:
COPD
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Simulation of pursed-lips breathing by defined stenoses in pulmonary function diagnostics to quantify the effect of the pursed-lips breathing
Detailed Description
Since many years it is recommended for COPD patients to reduce the crossdiameter of the lips in order to improve the exhalation by means of so-called pursed-lips breathing (PLB). But the effects have ...
Eligibility Criteria
Inclusion
- Patients:
- COPD (GOLD I- IV)
- Stable respiratory situation that allows routine lung funtion
- capable of communication
- Healthy:
- Lung Healthy
- capable of communication
Exclusion
- Invasive Ventilation
- Other serious acute physical illnesses that require immediate intensive medical treatment
- Acute hypercapnic decompensation with a pH \< 7.35 in the capillary BGA
- Pregnancy or Nursing
- Not able to give consent
- Not willing or able to follow the study protocol
Key Trial Info
Start Date :
September 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04663698
Start Date
September 11 2019
End Date
March 30 2021
Last Update
September 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Märkische Kliniken GmbH, Klinikum Lüdenscheid
Lüdenscheid, North Rhine-Westphalia, Germany, 58515